NCT03061734View on ClinicalTrials.gov

Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 18, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Migraine With or Without Aura
Interventions
DRUG

Naltrexone and Acetaminophen

Naltrexone plus acetaminophen

DRUG

Naltrexone and Acetaminophen-High Dose

Naltrexon (high dose) plus acetaminophen

DRUG

Naltrexone Alone (regular dose)

Naltrexone Alone plus Placebo

DRUG

Acetaminophen Alone

Acetaminophen Alone plus Placebo

DRUG

Matching Placebo

Two Placebo capsules

Trial Locations (1)

33181

Annette C. Toledano MD, North Miami

Sponsors
All Listed Sponsors
lead

Allodynic Therapeutics, Inc

INDUSTRY

NCT03061734 - Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter